We are live on !
Find out more
Performa Ltd (US) Portfolio holdings
AUM
$625M
Turnover
23.21%
1-Year Est. Return
11.07%
This Fund
S&P 500
This Quarter Est. Return
-3.63%
1 Year Est. Return
+11.07%
3 Year Est. Return
+59.58%
5 Year Est. Return
+51.95%
10 Year Est. Return
–
AUM
$210M
AUM Growth
+$6.92M
(+3.4%)
Cap. Flow
+$14.9M
Cap. Flow % of AUM
Cap. Flow %
7.1%
Top 10 Holdings %
Top 10 Hldgs %
92.9%
Holding
79
New
2
Increased
27
Reduced
16
Closed
2
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$11.7M |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$5.76M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.79M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.29M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.96M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$127K |
| 3 |
Invesco S&P 500 Quality ETF
SPHQ
|
+$52.5K |
| 4 |
UBS Group
UBS
|
+$38.9K |
| 5 |
VistaGen Therapeutics
VTGN
|
+$9.16K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.67% |
| 2 | Technology | 0.12% |
| 3 | Healthcare | 0.07% |
| 4 | Consumer Staples | 0.04% |
| 5 | Communication Services | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $85.9M | 40.81% |
200,870
-17,905
| -8% | -$7.96M |
2018 Q1
22 quarters
|
|
|
2
Vanguard S&P 500 ETF
VOO
$1.04T
| $44.4M | 21.09% |
113,021
+6,823
| +6% | +$2.79M |
2021 Q2
9 quarters
|
|
|
3
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $18M | 8.57% |
346,368
+213,332
| +160% | +$11.7M |
2021 Q2
9 quarters
|
|
|
4
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.26B
| $10.3M | 4.9% |
304,259
+32,133
| +12% | +$1.1M |
2021 Q2
9 quarters
|
|
5
VanEck Fallen Angel High Yield Bond ETF
ANGL
$2.83B
| $8.33M | 3.96% |
307,896
| – | – |
2021 Q2
9 quarters
|
|
6
iShares Russell 2000 Value ETF
IWN
$14B
| $7.67M | 3.65% |
56,590
+1,778
| +3% | +$255K |
2018 Q1
22 quarters
|
|
|
7
Invesco S&P 500 Quality ETF
SPHQ
$18.8B
| $5.77M | 2.74% |
115,290
-1,024
| -0.9% | -$52.5K |
2021 Q3
8 quarters
|
|
|
8
iShares MSCI USA Quality Factor ETF
QUAL
$48.6B
| $5.69M | 2.7% |
172,572
-3,728
| -2% | -$127K |
2021 Q3
8 quarters
|
|
|
9
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.5B
| $5.54M | 2.63% |
34,707
+34,444
| +13,097% | +$5.76M |
2023 Q2
1 quarter
|
|
|
10
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $3.88M | 1.84% |
74,778
+23,863
| +47% | +$1.29M |
2019 Q4
15 quarters
|
|
11
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.3B
| $3.87M | 1.84% |
18,047
+26
| +0.1% | +$5.91K |
2020 Q1
14 quarters
|
|
12
iShares Core S&P Small-Cap ETF
IJR
$106B
| $3.38M | 1.61% |
35,851
| – | – |
2021 Q2
9 quarters
|
|
13
iShares MSCI Japan ETF
EWJ
$23.3B
| $2.12M | 1.01% |
35,221
| – | – |
2021 Q1
10 quarters
|
|
14
iShares Select Dividend ETF
DVY
$23.8B
| $1.82M | 0.86% |
16,899
| – | – |
2023 Q1
2 quarters
|
|
15
State Street SPDR S&P Dividend ETF
SDY
$22.7B
| $1.7M | 0.81% |
14,763
| – | – |
2023 Q1
2 quarters
|
|
16
State Street SPDR S&P Regional Banking ETF
KRE
$4.72B
| $1.2M | 0.57% |
28,711
+2,476
| +9% | +$110K |
2023 Q1
2 quarters
|
|
17
iShares Russell Mid-Cap Growth ETF
IWP
$18.2B
| $132K | 0.06% |
1,445
| – | – |
2020 Q3
12 quarters
|
|
18
Oatly Group
OTLY
$244M
| $84.7K | 0.04% |
4,503
+997
| +28% | +$29K |
2021 Q3
8 quarters
|
|
19
Clover Health Investments
CLOV
$2.66B
| $75.6K | 0.04% |
70,000
| – | – |
2021 Q1
10 quarters
|
|
20
Lumen Technologies, Inc. Common Stock
LUMN
$4.22B
| $48.3K | 0.02% |
34,000
+10,000
| +42% | +$16.9K |
2020 Q4
11 quarters
|
|
21
Smartbird Inc
BIRD
$17.1M
| $36.1K | 0.02% |
1,625
| – | – |
2022 Q1
6 quarters
|
|
22
Paysafe
PSFE
$210M
| $34.8K | 0.02% |
2,900
+400
| +16% | +$4.87K |
2021 Q4
7 quarters
|
|
23
DocuSign
DOCU
$15.1B
| $34.6K | 0.02% |
825
+275
| +50% | +$13.5K |
2021 Q4
7 quarters
|
|
24
Maravai LifeSciences
MRVI
$1.13B
| $28.2K | 0.01% |
2,825
+825
| +41% | +$9.06K |
2022 Q2
5 quarters
|
|
25
JetBlue
JBLU
$1.42B
| $26.2K | 0.01% |
5,700
+2,800
| +97% | +$18.4K |
2022 Q4
3 quarters
|
|
Similar funds
Performa Ltd (US)'s Q3 2023 Portfolio in Review
As of Q3 2023, Performa Ltd (US) held 79 positions worth $210M, up 3.4% from $203M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Performa Ltd (US) deployed $14.9M of net new capital in Q3 2023, opening 2 new positions and adding to 27 existing holdings. Its largest new stake was The RealReal: 1,000 shares worth $2.11K.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 100% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $7.96M trimmed.
- Performa Ltd (US)'s largest Q3 2023 buy was The RealReal: 1,000 shares worth $2.11K.
- Performa Ltd (US) added most to Vanguard Morningstar Mid-Cap ETF in Q3 2023, an estimated $11.7M increase.
- Performa Ltd (US)'s biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.96M.
- Performa Ltd (US) fully exited VistaGen Therapeutics in Q3 2023, selling an estimated $9.16K.
- Performa Ltd (US)'s ten largest holdings make up 93% of its $210M portfolio in Q3 2023.
- Performa Ltd (US) opened 2 new positions and closed 2 in Q3 2023.
- Performa Ltd (US)'s portfolio value rose 3.4% quarter-over-quarter to $210M.
Based on Performa Ltd (US)'s 13F filing for Q3 2023, filed 1 Nov 2023.